Michael Ackermann, Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 10,150 shares at $26.45 ($267K) on 2021-10-12, disclosed to the SEC on 2021-10-14.
Open-market sale of $267k TARS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.56 | 1,116 | $29K | 10.7% |
| 2 | $26.45 | 4,517 | $119K | 44.7% |
| 3 | $26.45 | 4,517 | $119K | 44.7% |
| Total | $26.35 avg | 10,150 | $267K | 100% |
| Filing → |
| TARS | SELL | 2021-11-03 | $300K | — | Filing → |
| TARS | SELL | 2021-10-12 | $5K | — | Filing → |
| TARS | SELL | 2021-09-03 | $294K | — | Filing → |